Correlation Between Paragon 28 and Bone Biologics

Can any of the company-specific risk be diversified away by investing in both Paragon 28 and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Paragon 28 and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Paragon 28 and Bone Biologics Corp, you can compare the effects of market volatilities on Paragon 28 and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Paragon 28 with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Paragon 28 and Bone Biologics.

Diversification Opportunities for Paragon 28 and Bone Biologics

-0.18

Correlation Coefficient

Paragon 28  Bone Biologics

Good diversification

The 3 months correlation between Paragon and Bone is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Paragon 28 and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Paragon 28 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Paragon 28 are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Paragon 28 i.e., Paragon 28 and Bone Biologics go up and down completely randomly.

Pair Corralation between Paragon 28 and Bone Biologics

Considering the 90-day investment horizon Paragon 28 is expected to generate 0.36 times more return on investment than Bone Biologics. However, Paragon 28 is 2.77 times less risky than Bone Biologics. It trades about 0.24 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.01 per unit of risk. If you would invest  1,025  in Paragon 28 on December 28, 2024 and sell it today you would earn a total of  276.00  from holding Paragon 28 or generate 26.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Paragon 28  vs.  Bone Biologics Corp

Paragon 28

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Paragon 28 are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Paragon 28 sustained solid returns over the last few months and may actually be approaching a breakup point.

Bone Biologics Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Bone Biologics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Paragon 28 and Bone Biologics

The main advantage of trading using opposite Paragon 28 and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Paragon 28 position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.

The idea behind Paragon 28 and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.